Further supporting these findings, studies in venous thromboembolism (VTE) have observed elevated levels of complement factor H-related protein 5 (CFHR5), a regulator of the C3 alternative pathway, in patients with acute VTE. Here, CFHR5 is linked to venous thromboembolism.